nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of DNA vaccines for the rabies-related virus, Mokola
|
Nel, L.H |
|
2003 |
21 |
19-20 |
p. 2598-2606 9 p. |
artikel |
2 |
Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?
|
Clarke, S.C. |
|
2003 |
21 |
19-20 |
p. 2468-2473 6 p. |
artikel |
3 |
Antibody response to vaccination and psychosocial stress in humans: relationships and mechanisms
|
Burns, Victoria E |
|
2003 |
21 |
19-20 |
p. 2523-2534 12 p. |
artikel |
4 |
Antigen entrapped in the escheriosomes leads to the generation of CD4+ helper and CD8+ cytotoxic T cell response
|
Syed, Faisal M. |
|
2003 |
21 |
19-20 |
p. 2383-2393 11 p. |
artikel |
5 |
A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant
|
Halperin, Scott A |
|
2003 |
21 |
19-20 |
p. 2461-2467 7 p. |
artikel |
6 |
A single amino acid substitution in a recombinant G protein vaccine drastically curtails protective immunity against respiratory syncytial virus (RSV)
|
Huang, Yan |
|
2003 |
21 |
19-20 |
p. 2500-2505 6 p. |
artikel |
7 |
Biodefense Vaccines, Therapeutics and Diagnostics: Policy, Funding, Development, Testing, Production, and Distribution Conference, June 2–4, 2003, Washington, DC
|
|
|
2003 |
21 |
19-20 |
p. 2690- 1 p. |
artikel |
8 |
CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation
|
Brandão, Joana G. |
|
2003 |
21 |
19-20 |
p. 2268-2272 5 p. |
artikel |
9 |
Cellular immune responses to helper-free HSV-1 amplicon particles encoding HIV-1 gp120 are enhanced by DNA priming
|
Wang, Xiuqing |
|
2003 |
21 |
19-20 |
p. 2288-2297 10 p. |
artikel |
10 |
Comments on the paper “The effectiveness of serogroup C meningococcal vaccine estimated from routine surveillance data” [P. Rivest, R. Allard, Vaccine 20 (2002) 2533–2536]
|
De Wals, Philippe |
|
2003 |
21 |
19-20 |
p. 2260-2261 2 p. |
artikel |
11 |
CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal mice
|
Pihlgren, Maria |
|
2003 |
21 |
19-20 |
p. 2492-2499 8 p. |
artikel |
12 |
Development and clinical testing of multivalent vaccines based on a diphtheria–tetanus–acellular pertussis vaccine: difficulties encountered and lessons learned
|
Capiau, Carine |
|
2003 |
21 |
19-20 |
p. 2273-2287 15 p. |
artikel |
13 |
Editorial Board
|
|
|
2003 |
21 |
19-20 |
p. IFC- 1 p. |
artikel |
14 |
Effect of infant immunisation with meningococcus serogroup C–CRM197 conjugate vaccine on diphtheria immunity and reactogenicity in pre-school aged children
|
McVernon, Jodie |
|
2003 |
21 |
19-20 |
p. 2573-2579 7 p. |
artikel |
15 |
Effect of priming/booster immunisation protocols on immune response to canine parvovirus peptide induced by vaccination with a chimaeric plant virus construct
|
Nicholas, B.L. |
|
2003 |
21 |
19-20 |
p. 2441-2447 7 p. |
artikel |
16 |
Effect of Vitamin A supplementation on the immune response to measles vaccination
|
Cherian, Thomas |
|
2003 |
21 |
19-20 |
p. 2418-2420 3 p. |
artikel |
17 |
Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate
|
Plotnicky, Hélène |
|
2003 |
21 |
19-20 |
p. 2651-2660 10 p. |
artikel |
18 |
Enhanced tumour growth after DNA vaccination against human papilloma virus E7 oncoprotein: evidence for tumour-induced immune deviation
|
Kotecha, Minal T. |
|
2003 |
21 |
19-20 |
p. 2506-2515 10 p. |
artikel |
19 |
Erratum to “Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum” [Vaccine 21 (2003) 269–280]
|
Edelman, Robert |
|
2003 |
21 |
19-20 |
p. 2689- 1 p. |
artikel |
20 |
Gene expression after vaccination of mice with formulations of diphtheria toxoid or tetanus toxoid and different adjuvants: identification of shared and vaccine-specific genes in spleen lymphocytes
|
Regnström, Karin |
|
2003 |
21 |
19-20 |
p. 2307-2317 11 p. |
artikel |
21 |
Genetic immunization is augmented by murine polyomavirus VP1 pseudocapsids
|
Rollman, E. |
|
2003 |
21 |
19-20 |
p. 2263-2267 5 p. |
artikel |
22 |
HAV infection in chronic liver disease: a rationale for vaccination
|
Almasio, Piero L. |
|
2003 |
21 |
19-20 |
p. 2238-2241 4 p. |
artikel |
23 |
Hepatitis A: post-exposure prophylaxis
|
Taliani, Gloria |
|
2003 |
21 |
19-20 |
p. 2234-2237 4 p. |
artikel |
24 |
Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants
|
Yeh, Sylvia H |
|
2003 |
21 |
19-20 |
p. 2627-2631 5 p. |
artikel |
25 |
Identification of specific Hep G2 cell binding regions in Plasmodium falciparum sporozoite–threonine–asparagine-rich protein (STARP)
|
López, Ramsés |
|
2003 |
21 |
19-20 |
p. 2404-2411 8 p. |
artikel |
26 |
IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis
|
de Oliveira Mendes, Carolina |
|
2003 |
21 |
19-20 |
p. 2589-2597 9 p. |
artikel |
27 |
Immunogenicity and efficacy of recombinant subunit vaccines against phocid herpesvirus type 1
|
Martina, Byron E.E |
|
2003 |
21 |
19-20 |
p. 2433-2440 8 p. |
artikel |
28 |
Immunogenicity of a Japanese encephalitis DNA vaccine candidate in cynomolgus monkeys
|
Tanabayashi, Kiyoshi |
|
2003 |
21 |
19-20 |
p. 2338-2345 8 p. |
artikel |
29 |
Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis
|
Piedra, Pedro A. |
|
2003 |
21 |
19-20 |
p. 2448-2460 13 p. |
artikel |
30 |
Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2
|
Mozdzanowska, Krystyna |
|
2003 |
21 |
19-20 |
p. 2616-2626 11 p. |
artikel |
31 |
Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2)
|
Nguyen, Christophe L. |
|
2003 |
21 |
19-20 |
p. 2318-2328 11 p. |
artikel |
32 |
Modifications of the catalytic and binding subunits of pertussis toxin by formaldehyde: effects on toxicity and immunogenicity
|
Fowler, Sarah |
|
2003 |
21 |
19-20 |
p. 2329-2337 9 p. |
artikel |
33 |
Mucosal immunization with a replication-deficient adenovirus vector expressing murine cytomegalovirus glycoprotein B induces mucosal and systemic immunity
|
Shanley, John D. |
|
2003 |
21 |
19-20 |
p. 2632-2642 11 p. |
artikel |
34 |
Murine antibody response to intranasally administered enterotoxigenic Escherichia coli colonization factor CS6
|
de Lorimier, Arthur J |
|
2003 |
21 |
19-20 |
p. 2548-2555 8 p. |
artikel |
35 |
Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine
|
Halperin, Scott A. |
|
2003 |
21 |
19-20 |
p. 2298-2306 9 p. |
artikel |
36 |
Novel configurations of high molecular weight species of the pertussis toxin vaccine component
|
Fowler, Sarah |
|
2003 |
21 |
19-20 |
p. 2678-2688 11 p. |
artikel |
37 |
Oculo-respiratory syndrome following influenza vaccination: evidence for occurrence with more than one influenza vaccine
|
De Serres, Gaston |
|
2003 |
21 |
19-20 |
p. 2346-2353 8 p. |
artikel |
38 |
OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242–310 from the circumsporozoite protein of Plasmodium berghei
|
Meraldi, Valentin |
|
2003 |
21 |
19-20 |
p. 2485-2491 7 p. |
artikel |
39 |
Optimization of DNA vaccination immune responses in dairy cows: effect of injection site and the targeting efficacy of antigen-bCTLA-4 complex
|
Shkreta, Lulzim |
|
2003 |
21 |
19-20 |
p. 2372-2382 11 p. |
artikel |
40 |
Polyclonal antibodies to xenogeneic endothelial cells induce apoptosis and block support of tumor growth in mice
|
Scappaticci, F.A. |
|
2003 |
21 |
19-20 |
p. 2667-2677 11 p. |
artikel |
41 |
Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine
|
Purcell, Robert H |
|
2003 |
21 |
19-20 |
p. 2607-2615 9 p. |
artikel |
42 |
Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK.
|
Ramiro, Maria J. |
|
2003 |
21 |
19-20 |
p. 2474-2484 11 p. |
artikel |
43 |
Protective immune response against methicillin resistant Staphylococcus aureus in a murine model using a DNA vaccine approach
|
Senna, José P.M |
|
2003 |
21 |
19-20 |
p. 2661-2666 6 p. |
artikel |
44 |
Reconstruction of measles dynamics in a vaccinated population
|
Wallinga, J. |
|
2003 |
21 |
19-20 |
p. 2643-2650 8 p. |
artikel |
45 |
Reply to the letter of Drs De Wals and De Serres
|
Allard, Robert |
|
2003 |
21 |
19-20 |
p. 2262- 1 p. |
artikel |
46 |
Risk groups for hepatitis A virus infection
|
Franco, Elisabetta |
|
2003 |
21 |
19-20 |
p. 2224-2233 10 p. |
artikel |
47 |
Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia
|
Ito, Reiko |
|
2003 |
21 |
19-20 |
p. 2362-2371 10 p. |
artikel |
48 |
Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18–36 months of age
|
Qadri, Firdausi |
|
2003 |
21 |
19-20 |
p. 2394-2403 10 p. |
artikel |
49 |
Safety and protective efficacy of porcine reproductive and respiratory syndrome recombinant virus vaccines in young pigs
|
Verheije, M.H. |
|
2003 |
21 |
19-20 |
p. 2556-2563 8 p. |
artikel |
50 |
Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium)
|
Van der Wielen, Marie |
|
2003 |
21 |
19-20 |
p. 2412-2417 6 p. |
artikel |
51 |
Simian immunodeficiency virus: possible effects of deworming and tuberculin extrapolated to HIV/AIDS
|
Fincham, John E. |
|
2003 |
21 |
19-20 |
p. 2258-2259 2 p. |
artikel |
52 |
The association between psychosocial factors and vaccine-induced cytokine production
|
Hayney, Mary S. |
|
2003 |
21 |
19-20 |
p. 2428-2432 5 p. |
artikel |
53 |
The clinical spectrum of the oculo-respiratory syndrome after influenza vaccination
|
De Serres, Gaston |
|
2003 |
21 |
19-20 |
p. 2354-2361 8 p. |
artikel |
54 |
The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine
|
McIntosh, E.David G. |
|
2003 |
21 |
19-20 |
p. 2564-2572 9 p. |
artikel |
55 |
The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity
|
Wu, Suh-Chin |
|
2003 |
21 |
19-20 |
p. 2516-2522 7 p. |
artikel |
56 |
The effectiveness and safety of hepatitis A vaccine: a systematic review
|
Demicheli, Vittorio |
|
2003 |
21 |
19-20 |
p. 2242-2245 4 p. |
artikel |
57 |
The effect of measles–mumps–rubella (MMR) immunization on the immune responses of previously immunized primary school children
|
Rager-Zisman, Bracha |
|
2003 |
21 |
19-20 |
p. 2580-2588 9 p. |
artikel |
58 |
The incidence of shingles and its implications for vaccination policy
|
Chapman, Rachel S. |
|
2003 |
21 |
19-20 |
p. 2541-2547 7 p. |
artikel |
59 |
The role of vaccine in controlling hepatitis A epidemics
|
D’Argenio, P |
|
2003 |
21 |
19-20 |
p. 2246-2249 4 p. |
artikel |
60 |
The use of hepatitis a vaccination in Italy: an economic evaluation
|
Demicheli, Vittorio |
|
2003 |
21 |
19-20 |
p. 2250-2257 8 p. |
artikel |
61 |
The use of hepatitis A vaccine in Italy—evidence-based recommendations from an expert panel
|
Mele, Alfonso |
|
2003 |
21 |
19-20 |
p. 2223- 1 p. |
artikel |
62 |
Three types of immunotherapics against pythiosis insidiosi developed and evaluated
|
Santurio, J.M |
|
2003 |
21 |
19-20 |
p. 2535-2540 6 p. |
artikel |
63 |
Why do older people not get immunised against influenza?
|
Evans, Meirion R. |
|
2003 |
21 |
19-20 |
p. 2421-2427 7 p. |
artikel |